Soda-lime glass-coating containing silver nanoparticles on Ti-6Al-4V alloy

Journal of the European Ceramic Society

Volumn 32, Issue 11, 2012, Pages 2723-2729

  Esteban Tejeda, L ^a   Cabal, B ^a   Malpartida, F ^b   Lopez Piriz R ^c   Torrecillas, R ^c   Saiz, E ^d   Tomsia, A P ^e   Moya, J S ^a  

^a INSTITUTO DE CIENCIA DE MATERIALES DE MADRID   (Spain)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^c CINN CSIC UNIOVI PA   (Spain)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Biocide; Glass; Medical implants; Silver nanoparticles; Titanium alloy

Indexed keywords

BIOCIDAL ACTIVITY; FIRING CONDITIONS; GLASS COATING; GLASSY MATRICES; HUMAN TISSUES; IMPLANT INFECTIONS; MEDICAL IMPLANTS; METAL IMPLANTS; SILVER NANOPARTICLES; SODA LIME; TI-6AL-4V ALLOY;

BIOCIDES; COATINGS; GLASS; LIME; NANOPARTICLES; SURGERY; TISSUE; TITANIUM ALLOYS;

SILVER;

EID: 84861695294     PISSN: 09552219     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jeurceramsoc.2012.02.053     Document Type: Article

References (33)

1. Boodman SG, Maloney B. Replaceable you. The Washington Post; September 17 2007.
2. Schein H. Henry Schein enters growing dental implant category through strategic partnership with camlog 2004, Business Wire, Melville, NY, July 6.
3. Meier B. Absence of warranties for implants costs health system 2010, The New York Times, New York, April 2.
4. Pye A.D., Lockhart D.E.A., Dawson M.P., Murray C.A., Smith A.J. A review of dental implants and infection. J Hosp Infect 2009, 72(2):104-110.
5. Cramton S.E., Gerke C., Gotz F. In vitro methods to study staphylococcal biofilm formation. Methods Enzymol 2001, 336:239-255.
6. Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002, 15(2):167-193.
7. Bozic K.J., Ries M.D. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am 2005, 87(8):1746-1751.
8. 2. J Biomed Mater Res 2006, 8(3):595-604.
9. Singh P.K., Parsek M.R., Greensberg E.P., Welsh M.J. A component of innate immunity prevents bacterial biofilm development. Nature 2002, 17(6888):552-555.
10. Jiranek W., Hanssen A., Greenwald A.S. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Joint Surg Am 2006, 8(11):2487-2500.
11. Block J.E., Stubbs H.A. Reducing the risk of deep wound infection in primary joint arthroplasty with antibiotic bone cement. Orthopedics 2005, 8(11):1334-1345.
12. Dunbar M.J. Antibiotic bone cements: their use in routine primary total joint arthroplasty is justified. Orthopedics 2009, 2(9):660.
13. Hanssen A.D. Prophylactic use of antibiotic bone cement: an emerging standard-in opposition. J Arthroplasty 2004, 9(4):73-77.
14. Joseph T.N., Chen A.L., Di Cesare P.E. Use of antibiotic-impregnated cement in total joint arthroplasty. J Am Acad Orthop Surg 2003, 1(1):38-47.
15. Namba R.S., Chen Y., Paxton E.W., Slipchenko T., Fithian D.C. Outcomes of routine use of antibiotic-loaded cement in primary total knee arthroplasty. J Arthroplasty 2009, 24(Suppl. 6):44-47.
16. Dueland R., Spadaro J.A., Rahn B.A. Silver antibacterial bone cement, comparison with gentamicin in experimental osteomyelitis. Clin Orthop Relat Res 1982, 69:264-268.
17. Vik H., Andersen K.J., Julshamn K., Todnem K. Neuropathy caused by silver absorption from arthroplasty cement. Lancet 1985, 1(8433). 872-872.
18. Sudmann E., Vik H., Rait M., Todnem K., Andersen K.J., Julsham K., et al. Systemic and local silver accumulation after total hip replacement using silver-impregnated bone cement. Med Prog Technol 1994, 20(3-4):179-184.
19. Spadaro J.A., Webster D.A., Becker R.O. Silver polymethyl methacrylate antibacterial bone cement. Clin Orthop Relat Res 1979, 143:266-270.
20. Tomsia A.P., Launey M., Lee J., Mankani M., Wegst U., Saiz E. Nanotechnology approaches to improve dental implants. Int J Oral Maxillofac Implants 2011, 26(Suppl):25-44.
21. Esteban-Tejeda L., Malpartida F., Pecharroman C., Moya J.S. High antibacterial and antifungal activity of silver monodispersed nanoparticles embedded in a glassy matrix. Adv Eng Mater 2010, 12(7):B292-B297.
22. Evans P.A., Stevens R., Binner J.G.P. Quantitative X-ray diffraction analysis of polymorphic mixes of pure zirconia. Br Ceram Trans 1984, 83:39-43.
23. Esteban-Cubillo A., Díaz C., Fernández A., Díaz L.A., Pecharromán C., Torrecillas R., et al. Silver nanoparticles supported on [alpha]-, [eta]- and [delta]-alumina. J Eur Ceram Soc 2006, 26(1-2):1-7.
24. Mie G. Articles on the optical characteristics of turbid tubes: especially colloidal metal solutions. Ann der Phys 1908, 25(3):377-445.
25. Senoy T., Saritha K.N., Jamal E.M.A., Al-Harthi S.H., Manoj Raama V., Anantharaman M.R. Size-dependent surface plasmon resonance in silver silica nanocomposites. Nanotechnology 2008, 7:075710.
26. Tomsia A.P., Pask J.A. Chemical reactions and adherence at glass/metal interfaces: an analysis. Dent Mater 1986, 2(1):10-16.
27. Saiz E., Cannon R.M., Tomsia A.P. High-temperature wetting and the work of adhesion in metal/oxide systems. Ann Rev Mater Res 2008, 38:197-226.
28. Randall M.G. Sintering theory and practice 1996, John Wiley and Sons.
29. Murray J.L., Bhansali J.K. The Ag-Ti (silver-titanium) system. Bull Alloy Phase Diagrams 1983, 4(2):178-183.
30. Van Loo F.J.J., Rijnders M.R., Rönka K.J., Gülpen J.H., Kodentsov A.A. Solid state diffusion and reactive phase formation. Solid State Ionics 1997, 95(1-2):95-106.
31. Panacek A., Kolar M., Vecerova R., Prucek R., Soukupova J., Krystof V., et al. Antifungal activity of silver nanoparticles against Candida spp. Biomaterials 2009, 30(31):6333-6340.
32. Zhao L., Wang H., Huo K., Cui L., Zhang W., Ni H., et al. Antibacterial nano-structured titania coating incorporated with silver nanoparticles. Biomaterials 2011, 32:5706-5716.
33. Song W.H., Ryu H.S., Hong S.H. Antibacterial properties of Ag (or Pt)-containing calcium phosphate coatings formed by micro-arc oxidation. J Biomed Mater Res A 2008, 88:246-254.